About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2024-02-27
2024-02-06
2024-01-31
2024-01-22
2024-01-19
2023-11-24
2023-11-24
2023-11-23
2023-11-06
2023-11-06
2023-10-20
2023-10-18
Previous
2 / 5
Next
Previous
2 / 5
Next
MindRank Recognized in HolonIQ 2023 East Asia Health Tech 200
MindRank Achieves Milestone in Merck China Knowledge Graph Project, Advancing New Drug R&D with Enhanced Intelligence Insights from AI Large Models
Bioorganic Chemistry | Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitors
MindRank Founder Zhangming Niu Named in 2023 Forbes China Outstanding Foreign Talent Selection Honoree List
MindRank and Henlius (2696.HK) Announce Strategic Collaboration for AI-Driven Development of Next-Gen Antibody Drug Conjugates (ADCs) and Anti-Aging Therapy Platform
Galen Growth | MindRank Features in the HealthTech 250 most promising early-stage Digital Health ventures list for 2023
MindRank Founder Zhangming Niu Awarded Forbes China 100 Outstanding Overseas Returnees
MindRank has Nominated Kinase Inhibitors as Preclinical Candidates with the Potential to be Best-in-Class for IND-Enabling Studies
MindRank Founder Zhangming Niu Named to Hurun China Under40s 2023
MindRank Nominates a Preclinical Candidate with Dual-Target Capabilities for IND-Enabling Studies, the “First-in-Class” in the DDR Area
News - MindRank
MindRank Awarded “Future Unicorn | The Inaugural Dual 30 AI Ranking of Innovative Companies” by KPMG China
Journal of Biomolecular Structure and Dynamics | The Binding Mechanism of Failed, in Processing and Succeed Inhibitors Target SARS-CoV-2 Main Protease
